Cite
Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome
MLA
Bu, Fengxiao, et al. “Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome.” American Journal of Kidney Diseases, vol. 65, no. 6, June 2015, pp. 968–69. EBSCOhost, https://doi.org/10.1053/j.ajkd.2015.02.326.
APA
Bu, F., Meyer, N. C., Zhang, Y., Borsa, N. G., Thomas, C., Nester, C., & Smith, R. J. H. (2015). Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome. American Journal of Kidney Diseases, 65(6), 968–969. https://doi.org/10.1053/j.ajkd.2015.02.326
Chicago
Bu, Fengxiao, Nicole C. Meyer, Yuzhou Zhang, Nicolo Ghiringhelli Borsa, Christie Thomas, Carla Nester, and Richard J.H. Smith. 2015. “Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome.” American Journal of Kidney Diseases 65 (6): 968–69. doi:10.1053/j.ajkd.2015.02.326.